DMBIO Y
LIVE

Serial Number

79148927

Owner

Meiji Seika Pharma CO., Ltd.

Filing Date

Dec 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

DMBIO Y Trademark

Serial Number: 79148927 • Registration: 4654830

DMBIO Y is a trademark filed by Meiji Seika Pharma CO., Ltd. on December 19, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Meiji Seika Pharma CO., Ltd. (16 trademarks)

No. 4-16, Kyobashi 2-Chome,

Entity Type: 03

DM Bio Limited (2 trademarks)

45, Jisikgiban-ro,

Entity Type: 99

Trademark Details

Filing Date

December 19, 2013

Registration Date

December 16, 2014

Published for Opposition

September 30, 2014

Cancellation Date

December 19, 2023

Goods & Services

Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer

Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceutical products

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 16, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 16, 2024 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2023 FINP
GENERIC MADRID TRANSACTION SENT TO IB
Jan 24, 2023 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 24, 2023 INNA
GENERIC MADRID TRANSACTION CREATED
Jan 24, 2023 XXCR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2022 FINO
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 2, 2022 INTR
NOTIFICATION PROCESSED BY IB
Aug 29, 2021 GPNX
REFUSAL PROCESSED BY IB
Jul 11, 2021 RFNT
CANCELLED SECTION 71
Jul 2, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 16, 2019 REM3
CHANGE OF OWNER RECEIVED FROM IB
Mar 9, 2017 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2015 FINV
FINAL DISPOSITION NOTICE SENT TO IB
May 7, 2015 FICS
FINAL DISPOSITION PROCESSED
May 7, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 16, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 16, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2014 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 26, 2014 PREV
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2014 REAP
ASSIGNED TO LIE
Aug 20, 2014 ALIE
REFUSAL PROCESSED BY IB
Aug 16, 2014 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2014 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 25, 2014 RFCS
REFUSAL PROCESSED BY MPU
Jul 25, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2014 RFCR
APPLICATION FILING RECEIPT MAILED
Jul 22, 2014 MAFR
NON-FINAL ACTION WRITTEN
Jul 21, 2014 CNRT
ASSIGNED TO EXAMINER
Jul 16, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 14, 2014 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 11, 2014 REPR